Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy

Use of Raman spectroscopy for the early detection of filaggrin-related atopic dermatitis.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2010

[Prognosis value of thrombin activatable fibrinolysis inhibitor concentration and C1040T polymorphism in acute myocardial infarction treated with fibrinolysis].

Medicina intensiva·2010

Ube2l3 gene expression is modulated by activation of the aryl hydrocarbon receptor: implications for p53 ubiquitination.

Biochemical pharmacology·2010

Lung-specific inactivation of CCAAT/enhancer binding protein alpha causes a pathological pattern characteristic of COPD.

The European respiratory journal·2009

New metabolites of fenofibrate in Sprague-Dawley rats by UPLC-ESI-QTOF-MS-based metabolomics coupled with LC-MS/MS.

Xenobiotica; the fate of foreign compounds in biological systems·2009

Endothelial progenitor cells in cell-based therapy for cardiovascular disease.

Cellular and molecular biology (Noisy-le-Grand, France)·2008

No evidence of a role for PPARgamma Pro12Ala polymorphism in endometrial cancer susceptibility.

Pharmacogenetics·2004

Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole.

Pharmacogenetics·2004

Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells.

Pharmacogenetics·2004

Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes.

Pharmacogenetics·2004

Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism.

Pharmacogenetics·2004

The human serotonin receptor 2B: coding region polymorphisms and association with vulnerability to illegal drug abuse.

Pharmacogenetics·2004

Related Experiment Videos

Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing

Related Concept Videos

Use of Raman spectroscopy for the early detection of filaggrin-related atopic dermatitis.

[Prognosis value of thrombin activatable fibrinolysis inhibitor concentration and C1040T polymorphism in acute myocardial infarction treated with fibrinolysis].

Ube2l3 gene expression is modulated by activation of the aryl hydrocarbon receptor: implications for p53 ubiquitination.

Lung-specific inactivation of CCAAT/enhancer binding protein alpha causes a pathological pattern characteristic of COPD.

New metabolites of fenofibrate in Sprague-Dawley rats by UPLC-ESI-QTOF-MS-based metabolomics coupled with LC-MS/MS.

Endothelial progenitor cells in cell-based therapy for cardiovascular disease.

No evidence of a role for PPARgamma Pro12Ala polymorphism in endometrial cancer susceptibility.

Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole.

Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells.

Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes.

Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism.

The human serotonin receptor 2B: coding region polymorphisms and association with vulnerability to illegal drug abuse.

Related Experiment Videos

Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing...

Related Concept Videos

Related Articles

Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing